US Map / Utah
State UT

Clinical Trials in Utah

Utah is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Utah and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 211 actively recruiting studies with Utah sites out of 211 registered in total. The busiest research areas in Utah are Breast Cancer, Advanced Solid Tumor, Advanced Solid Tumors. Leading sponsors running trials in the state include University of Utah, AstraZeneca, National Cancer Institute (NCI). By stage, Utah trials break down as Phase 1 (43), Phase 2 (64), Phase 3 (63), Phase 4 (9).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
211
Recruiting Now
211
← Back to US Map
Top Conditions in Utah
Breast Cancer (6)Advanced Solid Tumor (5)Advanced Solid Tumors (4)Acute Myeloid Leukemia (4)Multiple Myeloma (3)Fallopian Tube Cancer (3)Ulcerative Colitis (3)Obesity (3)Overweight (3)Pancreatic Adenocarcinoma (3)Endometrial Cancer (3)Melanoma (3)

Frequently Asked Questions — Clinical Trials in Utah

How many clinical trials are currently recruiting in Utah?
ClinicalMetric currently tracks 211 actively recruiting clinical trials with at least one location in Utah. The total number of registered studies—including active but not currently enrolling trials—is 211. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Utah?
Utah hosts clinical trials across a broad range of medical conditions, including Breast Cancer, Advanced Solid Tumor, Advanced Solid Tumors, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Utah serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Utah?
To join a clinical trial in Utah, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Utah maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Utah

NCT06581328 Phase 4
Recruiting
A Study of Vedolizumab in Adults With Ulcerative Colitis or Crohn's Disease in t...
Condition
Ulcerative Colitis
Enrollment
400 pts
Location
United States
Sponsor
Takeda
View Trial →
NCT04065399 Phase 1, Phase 2
Recruiting
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rea...
Condition
Acute Myeloid Leukemia
Enrollment
447 pts
Location
United States, Australia, Canada
Sponsor
Syndax Pharmaceuticals
View Trial →
NCT05229432 N/A
Recruiting
Study of Gastric Motility in Eosinophilic Gastritis
Condition
Eosinophilic Gastritis
Enrollment
30 pts
Location
United States
Sponsor
Children's Hospital Medical Ce
View Trial →
NCT04172532 Phase 1, Phase 2
Recruiting
Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual...
Condition
Locally Advanced Pancreatic Adenocarcinoma
Enrollment
92 pts
Location
United States
Sponsor
National Cancer Institute (NCI
View Trial →
NCT06883981 N/A
Recruiting
Capturing Autobiographical Memory Formation in Real World Spaces Using Multimoda...
Condition
Epilepsy
Enrollment
50 pts
Location
United States
Sponsor
University of Utah
View Trial →
NCT06307665 Phase 3
Recruiting
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As ...
Condition
Asthma
Enrollment
440 pts
Location
United States, China, Mexico
Sponsor
AstraZeneca
View Trial →
NCT06658899 Phase 2
Recruiting
A Phase 2 Study of CRD-4730 in CPVT
Condition
Catecholaminergic Polymorphic Ventricular Tachycardia
Enrollment
12 pts
Location
United States, Canada, France
Sponsor
Cardurion Pharmaceuticals, Inc
View Trial →
NCT05232916 Phase 3
Recruiting
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (...
Condition
Breast Cancer
Enrollment
2,250 pts
Location
United States, Belgium, France
Sponsor
Greenwich LifeSciences, Inc.
View Trial →
NCT07165132 Phase 1
Recruiting
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
Condition
GEP-NET
Enrollment
104 pts
Location
United States, Canada
Sponsor
RayzeBio, Inc.
View Trial →
NCT07282392 N/A
Recruiting
Helping Lupus Patients Manage Fibromyalgia Symptoms Through Emotional Awareness ...
Condition
Lupus
Enrollment
30 pts
Location
United States
Sponsor
University of Utah
View Trial →
NCT02523014 Phase 2
Recruiting
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating ...
Condition
Intracranial Meningioma
Enrollment
124 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT03150693 Phase 3
Recruiting
Inotuzumab Ozogamicin and Frontline Chemotherapy in Treating Young Adults With N...
Condition
B Acute Lymphoblastic Leukemia
Enrollment
303 pts
Location
United States, Canada
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT07114874 Phase 3
Recruiting
NBI-1117568-SCZ3032: Long-Term Evaluation of NBI-1117568 in Adults With Schizoph...
Condition
Schizophrenia
Enrollment
600 pts
Location
United States, Bulgaria, Romania
Sponsor
Neurocrine Biosciences
View Trial →
NCT06193889 Phase 2, Phase 3
Recruiting
KYSA-6: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy, in Patien...
Condition
Myasthenia Gravis
Enrollment
66 pts
Location
United States, Australia, Brazil
Sponsor
Kyverna Therapeutics
View Trial →
NCT06779773 N/A
Recruiting
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice ...
Condition
Geographic Atrophy
Enrollment
500 pts
Location
United States
Sponsor
Astellas Pharma Global Develop
View Trial →
NCT07003984 Phase 3
Recruiting
A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children.
Condition
Chikungunya Virus
Enrollment
720 pts
Location
United States, Philippines, Puerto Rico
Sponsor
Bavarian Nordic
View Trial →
NCT07730450 Phase 4
Recruiting
A Study to Learn About a COVID-19 Vaccine in Healthy Adults 18 Through 64 Years ...
Condition
COVID-19 Vaccines
Enrollment
200 pts
Location
United States
Sponsor
BioNTech SE
View Trial →
NCT05875168 Phase 1, Phase 2
Recruiting
First-in-Human Study of DS-3939a in Participants With Advanced Solid Tumors
Condition
Advanced Solid Tumor
Enrollment
590 pts
Location
United States, Belgium, Canada
Sponsor
Daiichi Sankyo
View Trial →
NCT05943535 Phase 3
Recruiting
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progre...
Condition
Progressive Pulmonary Fibrosis
Enrollment
698 pts
Location
United States, Argentina, Australia
Sponsor
United Therapeutics
View Trial →
NCT03180268 Phase 3
Recruiting
Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade...
Condition
Grade 2 Meningioma
Enrollment
163 pts
Location
United States, Canada, India
Sponsor
NRG Oncology
View Trial →
NCT06053190 N/A
Recruiting
Effects of Clear Speech on Listening Effort and Memory in Sentence Processing
Condition
Speech
Enrollment
80 pts
Location
United States
Sponsor
University of Utah
View Trial →
NCT06129240 N/A
Recruiting
An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability ...
Condition
Pulmonary Hypertension
Enrollment
80 pts
Location
United States
Sponsor
Liquidia Technologies, Inc.
View Trial →
NCT03003299 N/A
Recruiting
PARTNER 3 Trial - Aortic Valve-in-Valve
Condition
Aortic Stenosis
Enrollment
125 pts
Location
United States, Canada
Sponsor
Edwards Lifesciences
View Trial →
NCT06616584 Phase 2, Phase 3
Recruiting
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Adva...
Condition
Recurrent Lung Non-Small Cell Carcinoma
Enrollment
378 pts
Location
United States
Sponsor
SWOG Cancer Research Network
View Trial →
NCT06131840 Phase 1
Recruiting
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Condition
Colorectal Neoplasms
Enrollment
914 pts
Location
United States, Canada, China
Sponsor
Seagen, a wholly owned subsidi
View Trial →
Page 3 of 9 — 211 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology